Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity

Ruqayyah J. Almizraq, Philip J. Norris, Heather Inglis, Somaang Menocha, Mathijs R. Wirtz, Nicole Juffermans, Suchitra Pandey, Philip C. Spinella, Jason P. Acker, Jennifer A. Muszynski

Research output: Contribution to journalArticlepeer-review

32 Scopus citations


Transfusion of red cell concentrates (RCCs) is associated with increased risk of adverse outcomes thatmaybe affected by different blood manufacturing methods and the presence of extracellular vesicles (EVs).Weinvestigated the effect of different manufacturing methods on hemolysis, residual cells, cell-derived EVs, and immunomodulatory effects on monocyte activity. Thirty-two RCC units produced using whole blood filtration (WBF), red cell filtration (RCF), apheresis-derived (AD), and whole blood-derived (WBD) methods were examined (n 5 8 per method). Residual platelet and white blood cells (WBCs) and the concentration, cell of origin, and characterization of EVs in RCC supernatants were assessed in fresh and stored supernatants. Immunomodulatory activity of RCC supernatants was assessed by quantifying monocyte cytokine production capacity in an in vitro transfusion model. RCF units yielded the lowest number of platelet and WBC-derived EVs, whereas the highest number of platelet EVs was in AD (day 5) and in WBD (day 42). The number of small EVs (,200 nm) was greater than large EVs ($200 nm) in all tested supernatants, and the highest level of small EVs were in AD units. Immunomodulatory activity was mixed, with evidence of both inflammatory and immunosuppressive effects. Monocytes produced more inflammatory interleukin-8 after exposure to fresh WBF or expired WBD supernatants. Exposure to supernatants from AD and WBD RCC suppressed monocyte lipopolysaccharideinduced cytokine production. Manufacturing methods significantly affect RCC unit EV characteristics and are associated with an immunomodulatory effect of RCC supernatants, which may affect the quality and safety of RCCs.

Original languageEnglish
Pages (from-to)2296-2306
Number of pages11
JournalBlood Advances
Issue number18
StatePublished - Sep 25 2018


Dive into the research topics of 'Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity'. Together they form a unique fingerprint.

Cite this